Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profound Medical Corp. - common stock (NQ:PROF)

5.990 +0.010 (+0.17%)
Streaming Delayed Price Updated: 3:55 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 105,657
Open 5.840
Bid (Size) 5.600 (1,200)
Ask (Size) 6.200 (200)
Prev. Close 5.980
Today's Range 5.835 - 6.398
52wk Range 3.760 - 8.750
Shares Outstanding 20,208,948
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
Clinical validation from the Busch Center highlights the proven, scalable innovation driving a paradigm shift in prostate care — delivering precision treatment and better patient outcomes 
From Profound Medical Corp.
Via GlobeNewswire

Performance

YTD
-24.2%
-24.2%
1 Month
+0.2%
+0.2%
3 Month
+6.4%
+6.4%
6 Month
+40.0%
+40.0%
1 Year
-26.6%
-26.6%

More News

Read More
Earnings Scheduled For August 14, 2025
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
From Profound Medical Corp.
Via GlobeNewswire
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Posts Wider Loss in Q2
Via The Motley Fool
Profound Medical Announces Second Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
From Profound Medical Corp.
Via GlobeNewswire
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Profound Medical Announces First Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
From Profound Medical Corp.
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire

Frequently Asked Questions

Is Profound Medical Corp. - common stock publicly traded?
Yes, Profound Medical Corp. - common stock is publicly traded.
What exchange does Profound Medical Corp. - common stock trade on?
Profound Medical Corp. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Profound Medical Corp. - common stock?
The ticker symbol for Profound Medical Corp. - common stock is PROF on the Nasdaq Stock Market
What is the current price of Profound Medical Corp. - common stock?
The current price of Profound Medical Corp. - common stock is 5.990
When was Profound Medical Corp. - common stock last traded?
The last trade of Profound Medical Corp. - common stock was at 11/10/25 03:55 PM ET
What is the market capitalization of Profound Medical Corp. - common stock?
The market capitalization of Profound Medical Corp. - common stock is 121.05M
How many shares of Profound Medical Corp. - common stock are outstanding?
Profound Medical Corp. - common stock has 121M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.